Regulation of human microRNA biosynthesis and activity

人类 microRNA 生物合成和活性的调节

基本信息

  • 批准号:
    6928633
  • 负责人:
  • 金额:
    $ 30.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are an extensive family of~21 nt long non-coding RNAs that are expressed in a wide range of eukaryotes, including humans. Current evidence suggests that miRNAs play a key role in differentiation and development by inhibiting the translation of mRNAs bearing partially complementary target sites. This effect has been reproduced in human cells in this laboratory using model mRNA targets and authentic but over-expressed human miRNAs. MiRNAs are closely related to small interfering RNAs (siRNAs), non-coding ~21 nt RNAs that can be introduced into cells as synthetic RNAs or derived from short hairpin RNAs (shRNAs) transcribed from expression plasmids. Although siRNAs usually function by inducing the degradation of mRNAs bearing fully complementary target sites, recent evidence suggests that siRNAs and miRNAs may function via similar mechanisms. Because of the likely importance of miRNAs in regulating gene expression, and the potential of siRNAs as artificial regulators of gene expression, it is important to understand how human miRNAs are made and how they function, if for no other reason than to permit the optimization of gene inactivation strategies that depend on siRNAs. In specific aim 1, we will attempt to understand how the initial miRNA transcript is precisely processed to yield a single, ~21 nt mature mRNA. Specifically, we will define the RNA sequences or structures that mediate the specific nuclear excision of the ~70 nt pre-miRNA intermediate from this initial transcript, a processing event very recently proposed to be mediated by human RNAse III/drosha. Moreover, we will define the features of this pre-miRNA that mediate the subsequent, equally specific cytoplasmic excision of the mature miRNA by dicer. In specific aim 2, we will extend our initial data showing that Exportin 5 (Exp5) is required for nuclear export of both pre-miRNAs and shRNAs, and that Exp5 binds the former specifically, by defining the characteristics of pre-miRNAs that mediate Exp5 binding. Specific aim 3 focuses on understanding how miRNAs cooperate to inhibit mRNA translation while specific aim 4 seeks to understood how endogenous miRNA stability and function is impacted by introduction of exogenous siRNAs. Finally, in specific aim 5, we seek to extend our exciting initial data demonstrating inhibition of miRNA function by the adenovirus VA1 non-coding RNA by trying to define the underlying mechanism.
描述(由申请人提供):微小RNA(miRNA)是一个广泛的家族,长约21 nt,非编码RNA,在包括人类在内的广泛的真核生物中表达。目前的证据表明,miRNA通过抑制具有部分互补靶位点的mRNA的翻译在分化和发育中发挥关键作用。该实验室使用模型mRNA靶标和真实但过表达的人类miRNA在人类细胞中再现了这种效应。miRNA与小干扰RNA(siRNA)密切相关,小干扰RNA是非编码的~21 nt RNA,其可以作为合成RNA引入细胞或衍生自表达质粒转录的短发夹RNA(shRNA)。虽然siRNA通常通过诱导具有完全互补靶位点的mRNA的降解来发挥作用,但最近的证据表明siRNA和miRNA可能通过类似的机制发挥作用。由于miRNA在调节基因表达中的可能重要性,以及siRNA作为基因表达的人工调节剂的潜力,重要的是要了解人类miRNA是如何产生的以及它们是如何发挥作用的,如果没有其他原因,只为了允许优化依赖于siRNA的基因失活策略。在具体目标1中,我们将试图了解初始miRNA转录物如何精确加工以产生单个约21 nt的成熟mRNA。具体而言,我们将定义介导从该初始转录物中特异性核切除~70 nt前体miRNA中间体的RNA序列或结构,最近提出由人RNAse III/drosha介导的加工事件。此外,我们将定义这种pre-miRNA的特征,其介导随后的,同样特异性的成熟miRNA的细胞质切割。在具体目标2中,我们将通过定义介导Exp 5结合的pre-miRNA的特征来扩展我们的初始数据,该数据显示Exportin 5(Exp 5)是pre-miRNA和shRNAs的核输出所需的,并且Exp 5特异性地结合前者。具体目标3侧重于了解miRNA如何合作抑制mRNA翻译,而具体目标4则试图了解外源siRNA的引入如何影响内源性miRNA的稳定性和功能。最后,在具体的目标5中,我们试图通过定义潜在的机制来扩展我们令人兴奋的初始数据,这些数据证明了腺病毒VA 1非编码RNA对miRNA功能的抑制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRYAN R. CULLEN其他文献

BRYAN R. CULLEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRYAN R. CULLEN', 18)}}的其他基金

Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
逆转表观遗传沉默可挽救整合酶缺陷的 HIV-1 复制
  • 批准号:
    10158875
  • 财政年份:
    2021
  • 资助金额:
    $ 30.8万
  • 项目类别:
Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
逆转表观遗传沉默可挽救整合酶缺陷的 HIV-1 复制
  • 批准号:
    10369728
  • 财政年份:
    2021
  • 资助金额:
    $ 30.8万
  • 项目类别:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
HIV-1 转录本的表观转录组修饰:滥用药物的影响
  • 批准号:
    10371249
  • 财政年份:
    2018
  • 资助金额:
    $ 30.8万
  • 项目类别:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
HIV-1 转录本的表观转录组修饰:滥用药物的影响
  • 批准号:
    9894777
  • 财政年份:
    2018
  • 资助金额:
    $ 30.8万
  • 项目类别:
Effect of m6A editing of RNA on influenza A virus replication
RNA m6A 编辑对甲型流感病毒复制的影响
  • 批准号:
    9296268
  • 财政年份:
    2017
  • 资助金额:
    $ 30.8万
  • 项目类别:
Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases
使用 CRISPR/Cas 核酸内切酶破坏潜伏的 HIV-1 原病毒
  • 批准号:
    9427958
  • 财政年份:
    2015
  • 资助金额:
    $ 30.8万
  • 项目类别:
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
使用细菌 CRISPR/Cas 核酸内切酶选择性消除体内 HPV 转化细胞
  • 批准号:
    9136078
  • 财政年份:
    2015
  • 资助金额:
    $ 30.8万
  • 项目类别:
Reconstitution of a protective antiviral RNAi response in somatic human cells
重建人体细胞中保护性抗病毒 RNAi 反应
  • 批准号:
    8849841
  • 财政年份:
    2014
  • 资助金额:
    $ 30.8万
  • 项目类别:
Reconstitution of a protective antiviral RNAi response in somatic human cells
重建人体细胞中保护性抗病毒 RNAi 反应
  • 批准号:
    8762673
  • 财政年份:
    2014
  • 资助金额:
    $ 30.8万
  • 项目类别:
Role and mechanism of action of gamma herpesvirus microRNAs
γ 疱疹病毒 microRNA 的作用和作用机制
  • 批准号:
    8293437
  • 财政年份:
    2011
  • 资助金额:
    $ 30.8万
  • 项目类别:

相似海外基金

Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
  • 批准号:
    23K10830
  • 财政年份:
    2023
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10539405
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10688080
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
  • 批准号:
    DP220101361
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10677770
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
  • 批准号:
    RGPIN-2019-04411
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
  • 批准号:
    2143019
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
  • 批准号:
    486535
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10330828
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
  • 批准号:
    2046602
  • 财政年份:
    2021
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了